TNFRSF17 and Miyoshi myopathy: The authors attributed this lack of response to a lack of BCMA expression secondary to the biallelic loss of BCMA (monoallelic loss of 16 p and second copy loss-of-function mutation), which provides the molecular basis for the lack of BCMA expression in MM cells at the time of relapse.